This finding holds significant therapeutic promise since modulating Pfdn5 or Pfdn6 expression or stability could safely and effectively mitigate neurodegenerative diseases associated with microtubule instability, such as Tauopathies and possibly FUS-induced neurodegeneration (Kandhavivorn et al., 2023). The gene discussed is PFDN5; the disease is tauopathy.